327
Views
23
CrossRef citations to date
0
Altmetric
Gynaecology

The diagnostic value of β-human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions

, , , , , & show all
Pages 288-293 | Published online: 07 Apr 2010

References

  • Aksoy S, Celikkanat H, Senöz S, Gökmen O. 1996. The prognostic value of serum estradiol, progesterone, testosterone and free testosterone levels in detecting early abortions. European Journal of Obstetrics and Gynecology and Reproductive Biology 67:5–8.
  • Al Sebai MA, Diver M, Hipkin LJ. 1996. The role of a single free beta human chorionic in the diagnosis of early pregnancy failure and the prognosis of viability. Human Reproduction 11:881–888.
  • Al Sebai MAH, Kingsland JR, Diver M, Hipkin L, McFadyen IR. 1995. The role of a single progesterone measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. British Journal of Obstetrics and Gynaecology 102:364–369.
  • Bahl O. 1977. Human chorionic gonadotropin, its receptor and mechanism of action. FASEB Journal 36:2119–2127.
  • Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, van Kamb GJ, et al Maternal serum CA125 and CA 15–13 antigen levels in normal and pathological pregnancy. Fetal Diagnosis and Therapy 16:166–172.
  • Bora F, Boran B, Özen S, Ataşer G. 2002. The prognostic predictive value of serum CA-125, progesterone, estradiol, beta HCG levels in abortus imminens cases. Clinical Sciences and Doctor 8:759–763.
  • Brumsted JR, Nakajima ST, Badger G, Riddick DH, Gibson M. 1990. Serum concentration of CA 125 during the first trimester of normal and abnormal pregnancies. Journal of Reproductive Medicine 35:499–502.
  • Check JH, Nowroozi K, Winkel CA, Johnson T, Seefried L. 1990. Serum CA-125 levels in early pregnancy and subsequent spontaneous abortion. Obstetrics and Gynecology 75:742–744.
  • Cowan BD, Wandermolen DT, Long CA, Whitworth NS. 1992. Receiver-operator characteristic efficiency analysis, and predictive value of serum progesterone concentrations as a test for abnormal gestations. American Journal of Obstetrics and Gynecology 166:1729–1737.
  • Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, III, Hauth JC, Wenstrom KD. 2005. Abortus. In: Williams Obstetrics. 21st ed. Istanbul: Nobel Medical. pp 109–128.
  • Daily CA, Laurent SL, Nunley WC. 1994. The prognostic value of serum progesterone at quantitative HCG in early human pregnancy. American Journal of Obstetrics and Gynecology 171:1380–1384.
  • De Leon J, Sifuentes G, Hopkins C, Noble V, Gimpel T, Myles T, et al 2004. Maternal serum free β-HCG levels in uncomplicated pregnancies at the 10th–15th week of gestation and the development of obstetric complications. Journal of Reproductive Medicine 49:89–92.
  • Dugoff L, Hobbins JC, Malone TF, Porter TF, Luthy D, Comstock CH, et al 2004. First-trimester maternal serum PAPP-A and free beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial). American Journal of Obstetrics and Gynecology 191:1446–1451.
  • Evans MI, Krantz DA, Hallahan TW, Galen RS. 2007. Meta-analysis of first trimester Down syndrome screening studies: free β-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol. American Journal of Obstetrics and Gynecology 196:198–205.
  • Fan C, Goto S, Furuhashi Y, Tomoda Y. 1987. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease. Journal of Clinical Endocrinology and Metabolism 64:313–318.
  • Fiegler P, Katz M, Kaminski K, Rudol G. 2003. Clinical value of single serum CA 125 level in women with symptoms of imminent abortion during the first trimester of pregnancy. Journal of Reproductive Medicine 8:982–988.
  • Friedrich F, Salzer H, Ketemer P. 1984. Determination of progesterone in serum. Clinical significance in early pregnancy. Fortschritte der Medizin 102:1053–1055.
  • Hahlin M, Wallin A, Sjöblom P, Lindblom B. 1990. Single progesterone assays for early recognition of abnormal pregnancy. Human Reproduction 5:622–626.
  • Hornstein MD, Check JH, Hill JA. 1995. Serum CA 125 levels and spontaneous abortion. American Journal of Obstetrics and Gynecology 172:695–699.
  • Jouppila P, Huhtaniemi I, Tapanainen J. 1980. Early pregnancy failure: study by ultrasonic and hormonal methods. Obstetrics and Gynecology 55:42–47.
  • Kobayashi F, Sagawa N, Nanbu Y, Nakamura K, Nonogaki M, Ban C, et al 1989. Immunohistochemical localization and tissue levels of tumor-associated glycoproteins CA 125 and CA 19–19 in the decidua and fetal membranes at various gestational ages. American Journal of Obstetrics and Gynecology 160:1232–1238.
  • McCord ML, Muram D, Buster JE, Arheart KL, Stovall TG, Carson SA. 1996. Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance. Fertility and Sterility 66:513–516.
  • Nanbu Y, Fujii S, Konishi I, Nonogaki H, Mori T. 1989. CA-125 in the epithelium closely related to the embryonic ectoderm: the periderm and the amnion. American Journal of Obstetrics and Gynecology 161:462–467.
  • Nygreen KG, Johansson EDB, Wide L. 1973. Evaluation of the prognosis of threatened abortion from the peripheral plasma levels of progesterone, estradiol and human chorionic gonadotropin. American Journal of Obstetrics and Gynecology 116:916–922.
  • Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH. 2000. First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. British Journal of Obstetrics and Gynaecology 107:265–270.
  • Quirk GJ, Brunson GL, Long CA, Bannon GA, Sanders MM, Q'Brian TJ. 1989. CA 125 in tissues and amniotic fluid during pregnancy. American Journal of Obstetrics and Gynecology 159:644–649.
  • Riss PA, Radivojevic K, Bieglmayer C. 1989. Serum progesterone and human chorionic gonadotropin in very early pregnancy: implications for clinical management. European Journal of Obstetrics and Gynecology and Reproductive Biology 32:71–77.
  • Scarpellini F, Mastrone M, Sbracia M, Scarpellini L. 1995. Serum CA-125 and first trimester abortion. International Journal of Gynaecology and Obstetrics 49:259–264.
  • Schmidt T, Rein DT, Foth D, Eibach HW, Kurbacher CM, Mallmann P, et al 2001. Prognostic value of repeated serum CA 125 measurements in first trimester pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 7:168–173.
  • Yaron Y, Ochshorn Y, Heifetz S, Lehavi O, Sapir Y, Orr-Urtreger A. 2002. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagnosis and Therapy 17:352–356.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.